BenevolentAI
BenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
HQ location
London, United Kingdom
Website
Launch date
Employees
Market cap
$13.0m
- B2B
- manufacturing
- commission
- health
- pharmaceutical
- biotechnology
- artificial intelligence
- deep tech
- machine learning
- biotechnology
- sustainable development goals
- dt and ls
- core ai
- ai applications
- verified unicorns and $1b exits
- drug development
- nif defense security and resilience
- ai drug discovery
- techbio
- tech for biotech and pharma
- startup luxembourg
- digital pharma
- techbio drug discovery
- spac ipo announced
- spac target
- nif health crisis preparedness
- from $1b exit to zebra
- techscale200
- compbio
- nif biotech
- bia techbio uk
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor | €0.0 Valuation: €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | €135m Valuation: €1.5b | SPAC Private Placement | |
| Total Funding | 000k | ||
Woodford Investment Management(exited)
Lundbeck(exited)
Lansdowne Partners(exited)
Goldman Sachs(exited)
Temasek(exited)
AstraZeneca(exited)
Ally Bridge Group(exited)
Invus(exited)
Tech Nation(exited)
| GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 129 % | 15 % | (32 %) | 49 % | (33 %) | 128 % | (31 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | (1179 %) | (900 %) | (1806 %) | (1823 %) | (953 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (458 %) | (394 %) | (1044 %) | (802 %) | (1870 %) | (1552 %) | (864 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 427 % | 1377 % | 1049 % | 1018 % | 616 % | 829 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.